For stem cell experts, hopes are longterm
Human trials still years away in effort to cure paralysis
Carl T. Hall, Chronicle Science Writer
Monday, September 26, 2005
New evidence from mouse studies suggests that stem cells may help cure paralysis in cases of spinal cord injury. So that raises an obvious question: When can they be tried in humans?
The answer: No time soon.
That may be disappointing to paralyzed individuals with untreatable spinal cord damage, as well as champions of California's Proposition 71 stem cell research program, all anxious to see real treatments develop from the hype of regenerative medicine.
But experts warn it would be a big mistake to rush into clinical trials before settling the many scientific and ethical issues clouding the future of stem cell biology.
"I fully understand the impatience of patients, spinal cord injury patients in particular, who are desperate for some form of treatment. But there is risk proceeding too quickly here," said Dr. Arnold Kriegstein, a neurologist who serves as director of a stem cell and tissue biology program at UCSF.
"The whole field could be damaged by the outcome of one failed early trial," he said. "I am not saying (a human trial) shouldn't be done, but we should really be cautious about it."
Haste has laid waste in biomedicine before, most notably in the field known as human gene therapy. Trials were commenced in a flurry of early excitement but on shaky scientific ground. That led to shortcuts, serious ethical lapses and at least one widely reported death of a clinical trial participant.
Stem cell biologists are keenly aware of the gene therapy story -- and hope to avoid a sequel without being accused of dawdling too long in the face of unmet medical needs. The question came to the fore last week after UC Irvine researchers Aileen Anderson and Brian Cummings and colleagues documented improved coordination and mobility in spinal cord-injured mice after they were injected with some specialized stem cells of the nervous system.
http://sfgate.com/cgi-bin/article.cg...NG95EU12N1.DTL
Human trials still years away in effort to cure paralysis
Carl T. Hall, Chronicle Science Writer
Monday, September 26, 2005

- <LI class=print>Printable Version
- Email This Article
New evidence from mouse studies suggests that stem cells may help cure paralysis in cases of spinal cord injury. So that raises an obvious question: When can they be tried in humans?
The answer: No time soon.
That may be disappointing to paralyzed individuals with untreatable spinal cord damage, as well as champions of California's Proposition 71 stem cell research program, all anxious to see real treatments develop from the hype of regenerative medicine.
But experts warn it would be a big mistake to rush into clinical trials before settling the many scientific and ethical issues clouding the future of stem cell biology.
"I fully understand the impatience of patients, spinal cord injury patients in particular, who are desperate for some form of treatment. But there is risk proceeding too quickly here," said Dr. Arnold Kriegstein, a neurologist who serves as director of a stem cell and tissue biology program at UCSF.
"The whole field could be damaged by the outcome of one failed early trial," he said. "I am not saying (a human trial) shouldn't be done, but we should really be cautious about it."
Haste has laid waste in biomedicine before, most notably in the field known as human gene therapy. Trials were commenced in a flurry of early excitement but on shaky scientific ground. That led to shortcuts, serious ethical lapses and at least one widely reported death of a clinical trial participant.
Stem cell biologists are keenly aware of the gene therapy story -- and hope to avoid a sequel without being accused of dawdling too long in the face of unmet medical needs. The question came to the fore last week after UC Irvine researchers Aileen Anderson and Brian Cummings and colleagues documented improved coordination and mobility in spinal cord-injured mice after they were injected with some specialized stem cells of the nervous system.
http://sfgate.com/cgi-bin/article.cg...NG95EU12N1.DTL
Comment